Viewing Study NCT04393051

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:53 PM
Ignite Modification Date: 2026-05-16 @ 12:46 PM
Study NCT ID: NCT04393051
Status: UNKNOWN
Last Update Posted: 2020-05-20
First Post: 2020-05-16
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Baricitinib Compared to Standard Therapy in Patients With COVID-19
Sponsor: Azienda Ospedaliero, Universitaria Pisana
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Covid-19 View
None SARS-CoV 2 View
None SARS Pneumonia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None baricitinib View
None invasive ventilation View
None safety View
None pneumonia View
None SARS-CoV2 View
None Covid-19 View